REMEVi Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: coverage in all 50 states, which most sellers will not confirm
REMEVi's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
On the 52-week plan compounded semaglutide starts at $199/mo and tirzepatide at $269/mo, the same figure every month, nothing hidden, cancellable at will. REMEVi claims to be the first GLP-1 telehealth clinic working bilingually in English and Spanish, with clinicians trained in both rather than anything auto-translated. Providers manage titration weekly and an NPI-verified pharmacy ships overnight. Certification is LegitScript and licensure covers all 50 states plus DC. It discloses that compounded drugs are not FDA-approved. That pharmacy is verified by NPI but never named.
Is REMEVi legit?
Yes. REMEVi is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.8/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a REMEVi promo or coupon code?
We know of no promo or coupon code for REMEVi. Its listed price is $199 a month. Coupon sites advertising "REMEVi discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how REMEVi compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to REMEVi
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
REMEVi at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How REMEVi scores
Six columns, each one computed from something REMEVi has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.5/10$199/month is 8% above the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
8.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves 51 of 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on REMEVi
Last checked August 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for REMEVi
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with REMEVi involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1REMEVi shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2REMEVi does not require a live video visit before a first prescription.
- 3Ask REMEVi which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 4The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $269. That leaves out membership fees, first-month rates and insurance copays.
- REMEVi serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting REMEVi
- Phone
- (702) 352-4746
- REMEVi offers email support
Cancelling REMEVi
Taken from the terms REMEVi publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Refund policy present, terms not quoted
- Early-termination fee
- None
GLP-1 medications REMEVi offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Peptides REMEVi offers
REMEVi sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
52-week plan; month-to-month $279/mo. Same price every month (no titration hikes)
52-week plan; month-to-month $339/mo
Check the price yourself before you pay
Every figure here was read off REMEVi's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $269 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to REMEVi
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What REMEVi charges
The standing price at REMEVi is $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $269/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so REMEVi's $199 lands mid-market. Price is unlikely to be the deciding factor.
RNK Health dispenses semaglutide and tirzepatide from $197/month, which makes it the fair comparison to run before you commit here.
What REMEVi dispenses
REMEVi prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
Safety and disclosure
REMEVi tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. We found no FDA warning letters issued to REMEVi. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If REMEVi will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether REMEVi bills your plan before you start.
It fits if
- you need access wherever you live
Our read
REMEVi lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. HumeCare+ is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
REMEVi's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay REMEVi
Starting at $199 a month. Check today's price, then start the intake.
Where REMEVi is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare REMEVi head to head
The sellers closest to REMEVi on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this REMEVi review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See REMEVi's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.